Astrana Health (NASDAQ: ASTH) reported Q4 EPS of $0.26, $0.11 better than the analyst estimate of $0.15. Revenue for the quarter came in at $353 million versus the consensus estimate of $342 million.

GUIDANCE:

Astrana Health sees FY2024 EPS of $1.28-$1.52, versus the consensus of $1.59.

Astrana Health sees FY2024 revenue of $1.650-1.850 billion.

For earnings history and earnings-related data on (ASTH) click here.